TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism
about
Tyrosine phosphorylation in Toll-like receptor signalingThe Inflammatory Role of Platelets via Their TLRs and Siglec ReceptorsCpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signalingCardioprotective Effects of HuoxueAnshen Recipe against Myocardial Injuries Induced by Sleep Deprivation in Rats.MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6.Systemic stimulation of TLR2 impairs neonatal mouse brain development.The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen speciesTLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling.Poly (I:C) therapy decreases cerebral ischaemia/reperfusion injury via TLR3-mediated prevention of Fas/FADD interactionGlucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation.Interactions between Innate Immunity, Microbiota, and Probiotics.Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB activation in macrophages.The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage.Peptidoglycan Up-Regulates CXCL8 Expression via Multiple Pathways in Monocytes/Macrophages.TLR4 Deters Perfusion Recovery and Upregulates Toll-like Receptor 2 (TLR2) in Ischemic Skeletal Muscle and Endothelial CellsAttenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signalingSR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages.Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury.Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine production.Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis.The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signalingAttenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent.Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.MicroRNA-214 protects against hypoxia/reoxygenation induced cell damage and myocardial ischemia/reperfusion injury via suppression of PTEN and Bim1 expression.Toll-like receptors: new players in myocardial ischemia/reperfusion injury.The innate immune response in reperfused myocardium.Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogensRole of toll-like receptors in myocardial infarction.Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation.The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuliCRISPR-Cas9 mediated gene knockout in human coronary artery endothelial cells reveals a pro-inflammatory role of TLR2.Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathwayThe Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation.Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach.
P2860
Q26828015-F4CE83D4-20DA-45A3-BEAB-90E09F6A9F4AQ27004467-5B2B1DA7-FA1A-4F89-8C2B-7CBA4A07A4A0Q28487365-98C0B182-C633-425B-A57B-C81A66B968F6Q33578706-59DC9471-1BD8-42B5-8C0E-8AE9122BE4E6Q33648129-8415DCF2-9E74-4298-804B-BFC04FF34131Q33900585-8027B061-6938-4331-B41A-BB55CD880C33Q34297287-71D67D21-C323-46E8-B029-9B370F5F1652Q34482086-456248D2-2AD6-4F51-B8A7-D773D57294C2Q35118932-2674E112-FDCB-460D-9DEF-242A9973DCA8Q35206508-E37D958F-E2B5-4DD3-BB37-1BDBAB2FF033Q35315155-B2B76474-B17B-4CFA-AA79-EB1BFAAF16E3Q35668252-289D0C48-B0D8-4169-937C-1896A8F40AF2Q36055459-D220078D-ADB7-40DE-A768-FDF8433462E7Q36103464-D956019E-3674-43E2-9E30-D3B9ED010D56Q36218402-0E868E7B-D7C1-44F6-8894-B02BCE9E9070Q36307874-339CE5E6-80AE-490D-8005-1518AE8EDB61Q36399871-1F68C5D4-FBB1-4031-BCB5-D81385235195Q36453194-2FA73110-1FAF-4F38-A683-3003178D8096Q36456832-AB4A91E0-408C-4BC2-99B2-2C44889A6031Q36501225-268AE31A-AE22-4B9E-A687-0FE8CDB14D10Q36596636-B2DCE42B-5370-47EA-9D9A-D8B39008F0C8Q36717109-9F8A73F8-27C1-43F6-BC95-044C41CA12A7Q36825545-CBB49341-F13A-4B62-9DD4-E5DCBC389F6BQ36957263-EC16701D-6827-4348-BC24-C80CF35880F0Q37382986-22D24FDB-87A5-4249-86D3-D366EC6DD94FQ37429806-0593F46E-BB6E-4E35-A877-025EB2075D08Q37433294-460EA1A3-F51E-4DE9-A0C1-DE5688C9824FQ37699351-68D0EBC0-23B0-416B-A051-D76635A71BD6Q37810952-5F3CB152-75F7-41E6-B76B-0C712FCA1DA5Q37977824-BD61B716-6AA5-4A72-AF69-CE76B00E7086Q38018171-CA038395-C0C9-4BF2-9E9E-3F3FCC09012DQ38291083-CCA4F711-AABC-4989-8292-83738EAAAC24Q38711071-26CB0710-45FE-4CAE-A976-E469D8BE68C7Q38875774-571D620A-2090-42AB-8824-240CF3369896Q39549057-857B4351-C83C-4B1A-82D5-F844B6FBC605Q41990171-B11F2F68-9BCC-40AE-941A-D1F3D91C4D7DQ42144631-E1AF7CB4-0F7D-4799-8706-289B9D9D25E9Q42152131-AE067DC1-64DD-4AA2-A9F8-E3ED2A4F1290Q42152227-CC8EA2F7-89D2-4BC9-8E9A-C2B419425201Q42157765-5BB2983D-02A5-49F3-8A3B-2261F9EA6BAB
P2860
TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@ast
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@en
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@nl
type
label
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@ast
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@en
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@nl
prefLabel
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@ast
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@en
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@nl
P2093
P2860
P356
P1476
TLR2 ligands induce cardioprot ...... a PI3K/Akt-dependent mechanism
@en
P2093
Chuanfu Li
David L Williams
Jim Kelley
Julie R McMullen
Race L Kao
Tuanzhu Ha
P2860
P304
P356
10.1093/CVR/CVQ116
P577
2010-04-26T00:00:00Z